| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $723.0M | — | -3.7% |
| Cost of Revenue | $587.0M | — | -5.0% |
| R&D Expense | $1.0M | — | +0.0% |
| SG&A Expense | $91.0M | — | -24.2% |
| Interest Expense | $12.0M | — | +0.0% |
| Pre-tax Income | -$27.0M | — | +51.8% |
| Income Tax | $6.0M | — | +220.0% |
| Net Income | -$33.0M | — | +35.3% |
| EPS (Basic) | -$0.23 | — | +30.3% |
| EPS (Diluted) | -$0.23 | — | +30.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $228.0M | -2.1% | -17.7% |
| Accounts Receivable | $499.0M | -0.2% | +4.0% |
| Current Assets | $1.09B | +1.8% | -8.2% |
| Total Assets | $2.39B | -0.2% | -5.5% |
| Current Liabilities | $685.0M | +0.6% | -5.3% |
| Total Liabilities | $1.61B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.0M | — | +86.2% |
| Capital Expenditures | $9.0M | — | -35.7% |
| Investing Cash Flow | -$14.0M | — | +17.6% |
| Financing Cash Flow | $30.0M | — | +400.0% |
| Free Cash Flow | -$17.0M | — | +76.4% |
| +1.5% |
| Stockholders' Equity | $641.0M | -6.4% | -19.9% |